Found: 71
Select item for more details and to access through your institution.
Incorporation of TILs in daily breast cancer care: how much evidence can we bear?
- Published in:
- Virchows Archiv: European Journal of Pathology, 2022, v. 480, n. 1, p. 147, doi. 10.1007/s00428-022-03276-w
- By:
- Publication type:
- Article
Population-based Study of Prosigna-PAM50 and Outcome Among Postmenopausal Women With Estrogen Receptor-positive and HER2-negative Operable Invasive Lobular or Ductal Breast Cancer.
- Published in:
- 2020
- By:
- Publication type:
- journal article
The path to a better biomarker: application of a risk management framework for the implementation of PD‐L1 and TILs as immuno‐oncology biomarkers in breast cancer clinical trials and daily practice.
- Published in:
- Journal of Pathology, 2020, v. 250, n. 4, p. 667, doi. 10.1002/path.5406
- By:
- Publication type:
- Article
Adjuvant chemotherapy in patients with ER-negative/HER2-negative, T1abN0 breast cancer: a nationwide study.
- Published in:
- Breast Cancer Research & Treatment, 2023, v. 198, n. 1, p. 103, doi. 10.1007/s10549-022-06839-2
- By:
- Publication type:
- Article
Adjuvant chemotherapy in patients with ER-negative/HER2-negative, T1abN0 breast cancer: a nationwide study.
- Published in:
- Breast Cancer Research & Treatment, 2023, v. 197, n. 3, p. 103, doi. 10.1007/s10549-022-06839-2
- By:
- Publication type:
- Article
Benefit of adjuvant chemotherapy and trastuzumab in patients with HER2-positive, node-negative breast tumors ≤ 10 mm: a nationwide study.
- Published in:
- Breast Cancer Research & Treatment, 2022, v. 196, n. 1, p. 197, doi. 10.1007/s10549-022-06724-y
- By:
- Publication type:
- Article
Induction of PIK3CA alterations during neoadjuvant letrozole may improve outcome in postmenopausal breast cancer patients.
- Published in:
- Breast Cancer Research & Treatment, 2020, v. 184, n. 1, p. 123, doi. 10.1007/s10549-020-05833-w
- By:
- Publication type:
- Article
Inter‐observer agreement of tumor infiltrating lymphocytes in primary HER2‐positive breast cancer and correlation between tissue microarray and full tumor‐sections.
- Published in:
- APMIS, 2022, v. 130, n. 9, p. 545, doi. 10.1111/apm.13251
- By:
- Publication type:
- Article
Implementation of TMA and digitalization in routine diagnostics of breast pathology.
- Published in:
- APMIS, 2012, v. 120, n. 4, p. 341, doi. 10.1111/j.1600-0463.2011.02871.x
- By:
- Publication type:
- Article
Breast cancer in situ. From pre-malignant lesion of uncertain significance to well-defined non-invasive malignant lesion. The Danish Breast Cancer Cooperative Group Register 1977-2007 revisited.
- Published in:
- Acta Oncologica, 2008, v. 47, n. 4, p. 765, doi. 10.1080/02841860802043931
- By:
- Publication type:
- Article
Classical pathological variables recorded in the Danish Breast Cancer Cooperative Group's register 1978-2006.
- Published in:
- Acta Oncologica, 2008, v. 47, n. 4, p. 778, doi. 10.1080/02841860802039889
- By:
- Publication type:
- Article
Genomic Analyses of Breast Cancer Progression Reveal Distinct Routes of Metastasis Emergence.
- Published in:
- Scientific Reports, 2017, p. 43813, doi. 10.1038/srep43813
- By:
- Publication type:
- Article
Tumour-infiltrating lymphocytes and response to neoadjuvant letrozole in patients with early oestrogen receptor-positive breast cancer: analysis from a nationwide phase II DBCG trial.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Src Drives Growth of Antiestrogen Resistant Breast Cancer Cell Lines and Is a Marker for Reduced Benefit of Tamoxifen Treatment.
- Published in:
- PLoS ONE, 2015, v. 10, n. 2, p. 1, doi. 10.1371/journal.pone.0118346
- By:
- Publication type:
- Article
Classifications within Molecular Subtypes Enables Identification of <i>BRCA1/BRCA2</i> Mutation Carriers by RNA Tumor Profiling
- Published in:
- PLoS ONE, 2013, v. 8, n. 5, p. 1, doi. 10.1371/journal.pone.0064268
- By:
- Publication type:
- Article
Gene Expression Signatures That Predict Outcome of Tamoxifen-Treated Estrogen Receptor-Positive, High-Risk, Primary Breast Cancer Patients: A DBCG Study.
- Published in:
- PLoS ONE, 2013, v. 8, n. 1, p. 1, doi. 10.1371/journal.pone.0054078
- By:
- Publication type:
- Article
Global MicroRNA Expression Profiling of High-Risk ER+ Breast Cancers from Patients Receiving Adjuvant Tamoxifen Mono-Therapy: A DBCG Study.
- Published in:
- PLoS ONE, 2012, v. 7, n. 5, p. 1, doi. 10.1371/journal.pone.0036170
- By:
- Publication type:
- Article
Quantitative proteomics of primary tumors with varying metastatic capabilities using stable isotope-labeled proteins of multiple histogenic origins.
- Published in:
- Proteomics, 2012, v. 12, n. 13, p. 2139, doi. 10.1002/pmic.201100490
- By:
- Publication type:
- Article
MCM3 upregulation confers endocrine resistance in breast cancer and is a predictive marker of diminished tamoxifen benefit.
- Published in:
- NPJ Breast Cancer, 2021, v. 7, n. 1, p. 1, doi. 10.1038/s41523-020-00210-8
- By:
- Publication type:
- Article
The Prosigna 50-gene profile and responsiveness to adjuvant anthracycline-based chemotherapy in high-risk breast cancer patients.
- Published in:
- NPJ Breast Cancer, 2020, v. 6, n. 1, p. 1, doi. 10.1038/s41523-020-0148-0
- By:
- Publication type:
- Article
ONEST (Observers Needed to Evaluate Subjective Tests) Analysis of Stromal Tumour-Infiltrating Lymphocytes (sTILs) in Breast Cancer and Its Limitations.
- Published in:
- Cancers, 2023, v. 15, n. 4, p. 1199, doi. 10.3390/cancers15041199
- By:
- Publication type:
- Article
Neither Tumor-Infiltrating Lymphocytes nor Cytotoxic T Cells Predict Enhanced Benefit from Chemotherapy in the DBCG77B Phase III Clinical Trial.
- Published in:
- Cancers, 2022, v. 14, n. 15, p. 3808, doi. 10.3390/cancers14153808
- By:
- Publication type:
- Article
Intra-Tumour Heterogeneity Is One of the Main Sources of Inter-Observer Variation in Scoring Stromal Tumour Infiltrating Lymphocytes in Triple Negative Breast Cancer.
- Published in:
- Cancers, 2021, v. 13, n. 17, p. 4410, doi. 10.3390/cancers13174410
- By:
- Publication type:
- Article
The Prosigna gene expression assay and responsiveness to adjuvant cyclophosphamide-based chemotherapy in premenopausal high-risk patients with breast cancer.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Correlation between circulating cell‐free PIK3CA tumor DNA levels and treatment response in patients with PIK3CA‐mutated metastatic breast cancer.
- Published in:
- Molecular Oncology, 2018, v. 12, n. 6, p. 925, doi. 10.1002/1878-0261.12305
- By:
- Publication type:
- Article
Neo-train: study protocol and feasibility results for a two-arm randomized controlled trial investigating the effect of supervised exercise during neoadjuvant chemotherapy on tumour response in patients with breast cancer.
- Published in:
- BMC Cancer, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12885-023-11284-5
- By:
- Publication type:
- Article
Gene expression alterations associated with outcome in aromatase inhibitor-treated ER+ early-stage breast cancer patients.
- Published in:
- Breast Cancer Research & Treatment, 2015, v. 154, n. 3, p. 483, doi. 10.1007/s10549-015-3644-4
- By:
- Publication type:
- Article
The miRNA-200 family and miRNA-9 exhibit differential expression in primary versus corresponding metastatic tissue in breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2012, v. 134, n. 1, p. 207, doi. 10.1007/s10549-012-1969-9
- By:
- Publication type:
- Article
ER, HER2, and TOP2A expression in primary tumor, synchronous axillary nodes, and asynchronous metastases in breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2012, v. 132, n. 2, p. 511, doi. 10.1007/s10549-011-1610-3
- By:
- Publication type:
- Article
Amplification of ESR1 may predict resistance to adjuvant tamoxifen in postmenopausal patients with hormone receptor positive breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2011, v. 127, n. 2, p. 345, doi. 10.1007/s10549-010-0984-y
- By:
- Publication type:
- Article
Activation of ErbB3, EGFR and Erk is essential for growth of human breast cancer cell lines with acquired resistance to fulvestrant.
- Published in:
- Breast Cancer Research & Treatment, 2009, v. 114, n. 2, p. 263, doi. 10.1007/s10549-008-0011-8
- By:
- Publication type:
- Article
Cytokeratin on Frozen Sections of Sentinel Node May Spare Breast Cancer Patients Secondary Axillary Surgery.
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
Cytokeratin on Frozen Sections of Sentinel Node May Spare Breast Cancer Patients Secondary Axillary Surgery.
- Published in:
- Pathology Research International, 2012, p. 1, doi. 10.1155/2012/802184
- By:
- Publication type:
- Article
RNA profiling reveals familial aggregation of molecular subtypes in non-BRCA1/2 breast cancer families.
- Published in:
- BMC Medical Genomics, 2014, v. 7, n. 1, p. 1, doi. 10.1186/1755-8794-7-9
- By:
- Publication type:
- Article
A Multi-Stain Breast Cancer Histological Whole-Slide-Image Data Set from Routine Diagnostics.
- Published in:
- Scientific Data, 2023, v. 10, n. 1, p. 1, doi. 10.1038/s41597-023-02422-6
- By:
- Publication type:
- Article
Digital image analysis and assisted reading of the HER2 score display reduced concordance: pitfalls in the categorisation of HER2‐low breast cancer.
- Published in:
- Histopathology, 2023, v. 82, n. 6, p. 912, doi. 10.1111/his.14877
- By:
- Publication type:
- Article
Analytical validation of a standardised scoring protocol for Ki67 immunohistochemistry on breast cancer excision whole sections: an international multicentre collaboration.
- Published in:
- Histopathology, 2019, v. 75, n. 2, p. 225, doi. 10.1111/his.13880
- By:
- Publication type:
- Article
Application of automated image analysis reduces the workload of manual screening of sentinel lymph node biopsies in breast cancer.
- Published in:
- Histopathology, 2017, v. 71, n. 6, p. 866, doi. 10.1111/his.13305
- By:
- Publication type:
- Article
Basal biomarkers nestin and INPP4B predict gemcitabine benefit in metastatic breast cancer: Samples from the phase III SBG0102 clinical trial.
- Published in:
- International Journal of Cancer, 2019, v. 144, n. 10, p. 2578, doi. 10.1002/ijc.31969
- By:
- Publication type:
- Article
Evaluation of Nine Somatic Variant Callers for Detection of Somatic Mutations in Exome and Targeted Deep Sequencing Data.
- Published in:
- PLoS ONE, 2016, v. 11, n. 3, p. 1, doi. 10.1371/journal.pone.0151664
- By:
- Publication type:
- Article
Tumour-infiltrating CD4-, CD8- and FOXP3-positive immune cells as predictive markers of mortality in BRCA1- and BRCA2-associated breast cancer.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Breast cancer survival in Nordic BRCA2 mutation carriers-unconventional association with oestrogen receptor status.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Locoregional Lymph Node Metastasis from Clinically Occult Breast Cancer: Prognostic Significance of Mastectomy.
- Published in:
- Breast Journal, 2024, v. 2024, p. 1, doi. 10.1155/2024/5878308
- By:
- Publication type:
- Article
Evaluation of tumor-infiltrating lymphocytes, PD-L1, and PIK3CA mutations and association with prognosis in HER2-positive early stage breast cancer.
- Published in:
- Acta Oncologica, 2023, v. 62, n. 12, p. 1913, doi. 10.1080/0284186X.2023.2279685
- By:
- Publication type:
- Article
Calcium electroporation as an adjunct therapy for pembrolizumab-resistant bladder cancer: a case report.
- Published in:
- Acta Oncologica, 2023, v. 62, n. 6, p. 614, doi. 10.1080/0284186X.2023.2226330
- By:
- Publication type:
- Article
Is DBCG abreast of new developments?
- Published in:
- 2018
- By:
- Publication type:
- Editorial
The clinical database and implementation of treatment guidelines by the Danish Breast Cancer Cooperative Group in 2007–2016.
- Published in:
- Acta Oncologica, 2018, v. 57, n. 1, p. 13, doi. 10.1080/0284186X.2017.1404638
- By:
- Publication type:
- Article
Neoadjuvant letrozole for postmenopausal estrogen receptor-positive, HER2-negative breast cancer patients, a study from the Danish Breast Cancer Cooperative Group (DBCG).
- Published in:
- Acta Oncologica, 2018, v. 57, n. 1, p. 31, doi. 10.1080/0284186X.2017.1401228
- By:
- Publication type:
- Article
An inter-observer Ki67 reproducibility study applying two different assessment methods: on behalf of the Danish Scientific Committee of Pathology, Danish breast cancer cooperative group (DBCG).
- Published in:
- Acta Oncologica, 2018, v. 57, n. 1, p. 83, doi. 10.1080/0284186X.2017.1404127
- By:
- Publication type:
- Article
Mortality and recurrence rates among systemically untreated high risk breast cancer patients included in the DBCG 77 trials.
- Published in:
- Acta Oncologica, 2018, v. 57, n. 1, p. 135, doi. 10.1080/0284186X.2017.1400181
- By:
- Publication type:
- Article